IgG-NR2B—A Potentially Valuable Biomarker in the Management of Refractory Anti-NMDAR Encephalitis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020513 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zuzana Števková und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Neurology, Faculty Hospital Trnava, 917 02 Trnava, Slovakia. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Teratoma, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The autoantibodies against the NR1 subunit are well known in the pathomechanism of NMDAR encephalitis. The dysfunction of the NR2 subunit could be a critical factor in this neurological disorder due to its important role in the postsynaptic pathways that direct synaptic plasticity. We report a case of paraneoplastic anti-NMDAR encephalitis presented alongside very severe illness. Computed tomography (CT) of the brain, as well as FLAIR and T2-weighted MRI, was performed to rule out any other acute brain processes. A semi-quantitative method was applied to detect the presence of anti-NMDAR antibodies in the serum and CSF. A CT chest–abdomen–pelvis scan was performed that detected an ovarian teratoma. A histopathological examination was performed after a laparoscopic right-ovary cystectomy. Subsequent immunofluorescence immunohistochemical staining showed the expression of NMDA receptors of type NR2B. Treatment included first-line immunotherapy, second-line immunotherapy, tumor removal, and intrathecal injections with methotrexate and dexamethasone. The histological finding for our patient after tumor removal was ovarian teratoma. Hematoxylin–eosin (HE) staining revealed a characteristic spectrum of elements, including stratified squamous epithelium and fat tissue accompanied by neuroglial cells. Subsequent immunohistochemical staining showed an expression of NMDA receptors of type NR2B in different structures of the teratoma, including the neuroglial cells. The first-line immunotherapy following the tumor removal was insufficient in our patient. The paraneoplastic anti-NMDAR encephalitis with a coexpressed NR2B subunit on the neural cells of the ovarian teratoma may suggest a different inflammation process and could be the key factor in the pathomechanism and treatment of the refractory anti-NMDAR encephalitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Neurology, Faculty Hospital Trnava, 917 02 Trnava, Slovakia.
- Clinic of Neurology in Trnava, Slovak Medical University, 833 03 Bratislava, Slovakia.
- Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
- Jessenius Medical Faculty in Martin, Comenius University in Bratislava, 813 72 Bratislava, Slovakia.
- Department of Pathology, Faculty of Health Care and Social Work, Trnava University and University Hospital, 917 02 Trnava, Slovakia.
- Department of Pathology, Faculty of Medicine, Comenius University and University Hospital Bratislava, 811 08 Bratislava, Slovakia.
ORCID-Profile: Georgi Krastev
Zitieren
APA
Števková, Z., Krastev, G., Mako, M., & Čierna, Z. (2025). IgG-NR2B—A Potentially Valuable Biomarker in the Management of Refractory Anti-NMDAR Encephalitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020513
Vancouver
Števková Z, Krastev G, Mako M, Čierna Z. IgG-NR2B—A Potentially Valuable Biomarker in the Management of Refractory Anti-NMDAR Encephalitis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020513
BibTeX
@article{tevkov2025,
author = {Števková, Zuzana and Krastev, Georgi and Mako, Miroslav and Čierna, Zuzana},
title = {IgG-NR2B—A Potentially Valuable Biomarker in the Management of Refractory Anti-NMDAR Encephalitis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020513}
}
EUVIMED